“…Inconsistent documentation, limited knowledge about clozapine and a lack of communication between teams have previously been shown to limit improvements when abnormalities are detected. 4,6 Logistically, access to phlebotomy-trained staff was a key barrier to on-schedule monitoring, which has been highlighted in previous audits of clozapine monitoring. 2,3 From a patient perspective, monitoring was passive, and many had little insight into the monitoring requirements.…”